Biennial International LRRK2 Conference

The meeting highlights how advances in human genetics can be translated into mechanistic insights, biomarker development and ultimately novel therapies, while bringing together all stakeholders involved in this process, including basic scientists, clinicians, industry partners, patients and charitable organisations.